Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
0.680
+0.010 (1.49%)
At close: Apr 26, 2024, 4:00 PM
0.688
+0.008 (1.18%)
After-hours: Apr 26, 2024, 7:52 PM EDT

Clover Health Investments Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
122.86103.79299.9792.3567.675.4
Short-Term Investments
119.82230.97315.294.36138.6411.12
Cash & Cash Equivalents
242.69334.76615.2696.71206.2486.52
Cash Growth
-27.50%-45.59%536.18%-53.11%138.37%-
Receivables
91.76147.1674.4950.1131.885.02
Other Current Assets
93.53143.0862.842.9614.9222.93
Total Current Assets
427.97625752.55189.78252.96194.46
Property, Plant & Equipment
8.469.787.659.9613.043.21
Long-Term Investments
121138.11175.9454.3957.090.7
Goodwill and Intangibles
2.99204.234.234.232.99
Other Long-Term Assets
10.2515.7410.438.899.79.24
Total Long-Term Assets
142.7183.62198.2677.4784.0716.13
Total Assets
570.67808.62950.8267.25337.02210.6
Accounts Payable
218.71324.15206.83134.6597.71132.16
Deferred Revenue
3.100000
Current Debt
1.671.833.0625.623.2439.29
Other Current Liabilities
37.65105.53162.743.9820.9315.64
Total Current Liabilities
261.12431.51372.62164.23141.89187.09
Long-Term Debt
34.0324.77112.7667.9649.25
Other Long-Term Liabilities
20.1616.1914.1155.71167.9629.08
Total Long-Term Liabilities
23.1620.2338.86268.47235.9278.33
Total Liabilities
284.28451.73411.49432.7377.81265.42
Total Debt
4.665.8627.83138.3691.288.54
Debt Growth
-20.43%-78.94%-79.89%51.71%3.00%-
Retained Earnings
-2,159.79-1,946.43-1,616.74-1,028.98-891.63-527.9
Comprehensive Income
-2.37-9.37-1.930.010.050
Shareholders' Equity
286.39356.89535.41-617.1-488.54-502.57
Net Cash / Debt
238.02328.9587.43-41.65115.03-2.03
Net Cash / Debt Growth
-27.63%-44.01%----
Net Cash Per Share
0.490.691.42-0.471.31-0.05
Working Capital
166.86193.49379.9225.55111.077.37
Book Value Per Share
0.590.751.30-6.96-5.56-11.96
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).